Berlin, Germany – caprotec bioanalytics GmbH announced today that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) Technology to analyze the binding characteristics and interaction of one undisclosed drug candidate with its human target proteins. For […]
NEW YORK – Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the “sixth DNA base,” 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit (https://www.epigentek.com/hydroxymethylation), for […]
AMSBIO has announced an expanded range of assay kits for the detection and quantification of oxidative stress biomarkers and antioxidants. Accurate, simple oxidative stress kits are now available from AMSBIO to analyse biomarkers of DNA, lipid and protein oxidative modification in biological samples. High sensitivity assays for 8-oxo dG (8-OHDG), Nitrotyrosine, Protein Carbonyl, Malondialdehyde, 8-isoprostane, […]
Chemical Determinants of DNA Ligase Fidelity SAN DIEGO – The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase. In these continued studies, the utility of chemically modified components will be explored […]
First Custom “Preps” Shipped Cambridgeshire, UK – Quotient Bioresearch, a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide, today announced that its new, state-of-the-art radiochemistry facility in Cardiff, UK is fully operational and that shipments of radiolabelled products have commenced. All staff have successfully transferred […]
Ann Arbor, USA and Zurich, Switzerland – Essen BioScience Inc. – a specialty provider of cell-based assay solutions and contract research services – and Nycomed – a privately owned global pharmaceutical company headquartered in Zurich, Switzerland – are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain […]
Fremont, CA – Antimicrobial peptides (AMPs) are peptides that form part of the host’s important innate immunity mechanism against pathogenic microorganisms such as Gram positive and negative bacteria, fungi and viruses.1-2 AMPs are short peptides (
RESEARCH TRIANGLE PARK, North Carolina — Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has now issued Actions Closing Prosecution in the reexamination proceedings for both U.S. Pat. No. 6,610,545 (“the ‘545 patent”) and U.S. Pat. No. 7,309,605 (“the ‘605 patent”) that are owned by the Institut Pasteur and […]
Menlo Park, CA – DNA2.0 , the leading gene synthesis and protein engineering company, today announced the availability of an innovative software tool for designing DNA sequences: Gene Designer 2.0 . Building on the success of the original Gene Designer, version 2.0 delivers a sophisticated graphic interface and drag-and-drop functionality for creating genes, whether making […]
AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. Fremont, CA — AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
